1990•PubMedRequires access

[Routine control of type 2 diabetes. Are glycosylated hemoglobin and fructosamine measurements necessary?].

A Tryggeseth

Open publisher page 2 citations

Abstract

In 98 type 2-diabetics with stable fasting blood glucose who were treated by tablets and/or diet, fasting blood glucose, glycosylated hemoglobin A1c and serum fructosamine were measured simultaneously. Fasting blood glucose was defined as stable when all values were less than 7.1 mmol/l, or deviated by less than 20% in at least three months, and the treatment had not been changed during the last six months. There is satisfactory correlation between fasting blood glucose and glycosylated hemoglobin A1c (r = 0.64), and serum fructosamine (r = 0.63). It is concluded that glycosylated hemoglobin and fructosamine are superfluous in routine controls of such patients. When fasting blood glucose is unsuitable for practical reasons, fructosamine is a good and cheap alternative. In annual controls glycosylated hemoglobin is the best parameter, and reflects the longest period of metabolic control.

About this research paper

What this paper is about

In 98 type 2-diabetics with stable fasting blood glucose who were treated by tablets and/or diet, fasting blood glucose, glycosylated hemoglobin A1c and serum fructosamine were measured simultaneously. Fasting blood glucose was defined as stable when all values were less than 7.1 mmol/l, or deviated by less than 20% in at least three months, and the treatment had not been changed during the last six months. There is satisfactory correlation between fasting blood glucose and glycosylated hemoglobin A1c (r = 0.64), and serum fructosamine (r = 0.63). It is concluded that glycosylated hemoglobin and fructosamine are superfluous in routine controls of such patients. When fasting blood glucose is unsuitable for practical reasons, fructosamine is a good and cheap alternative. In annual controls glycosylated hemoglobin is the best parameter, and reflects the longest period of metabolic control.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

In 98 type 2-diabetics with stable fasting blood glucose who were treated by tablets and/or diet, fasting blood glucose, glycosylated hemoglobin A1c and serum fructosamine were measured simultaneously. Fasting blood glucose was defined as stable when all values were less than 7.1 mmol/l, or deviated by less than 20% in at least three months, and the treatment had not been changed during the last six months. There is satisfactory correlation between fasting blood glucose and glycosylated hemoglobin A1c (r = 0.64), and serum fructosamine (r = 0.63). It is concluded that glycosylated hemoglobin and fructosamine are superfluous in routine controls of such patients. When fasting blood glucose is unsuitable for practical reasons, fructosamine is a good and cheap alternative. In annual controls glycosylated hemoglobin is the best parameter, and reflects the longest period of metabolic control.

Key concepts: Fructosamine, Hemoglobin, Medicine, Internal medicine, Diabetes mellitus, Endocrinology, Metabolic control analysis, Glycosylated haemoglobin

Related papers

Back to paper searchBrowse research topicsOriginal source
[Routine control of type 2 diabetes. Are glycosylated hemoglobin and fructosamine measurements necessary?]. — Research Paper | ScholarLens